Last updated: February 22, 2026
What Is the Scope of Patent DK3256138?
Patent DK3256138 pertains to a pharmaceutical invention with emphasis on the formulation and method of use related to a specific drug compound or combination. The patent’s scope is defined primarily through its claims, which specify the boundaries of protection. The patent aims to safeguard novel aspects such as the active ingredient(s), delivery mechanism, or therapeutic application.
The patent covers:
- Specific drug compositions, including molecules and their derivatives.
- Delivery methods, such as oral, injectable, or topical applications.
- Therapeutic uses, including indications and treatment protocols.
- Novel formulations, such as controlled-release matrices or combination therapies.
The scope does not extend to prior art compounds, known delivery technologies, or standard therapeutic uses outside the patent's claims.
How Are the Claims Structured?
Patent claims in DK3256138 are categorized into independent and dependent claims.
Independent Claims:
- Cover the broadest scope, describing the core invention.
- Usually encompass a novel compound, its method of synthesis, or a primary therapeutic use.
- Example (hypothetical): "A pharmaceutical composition comprising compound X or a pharmaceutically acceptable salt thereof for treating condition Y."
Dependent Claims:
- Narrow scope, adding specificity to independent claims.
- Cover particular embodiments, such as specific dosage forms, concentration ranges, or manufacturing methods.
Claim Types:
- Composition claims: Property of the drug formulation.
- Method claims: Process for manufacturing or administering the drug.
- Use claims: Therapeutic indications and applications.
Typical Claim Language:
Claims specify molecular structures with particular substitutions, formulations with specific excipients, or methods involving certain dosing regimens.
Patent Landscape Overview
Geographic Scope
- Enforced primarily in Denmark.
- Likely counterparts filed in major jurisdictions (EU, US, Asia).
Competitor and Patent Family Context
- Multiple patents on similar molecular classes exist.
- Patent families include filings in the European Patent Office and in the US.
- Prior art includes earlier patents on drug compositions, delivery systems, and therapeutic methods.
Citation Analysis
- Cited references include earlier patents on similar compounds, formulations, and treatment methods.
- Cited prior art spans from chemical synthesis techniques to therapeutic use claims.
Trends
- Recent filings show emphasis on novel delivery mechanisms and combination therapies.
- Patent filings related to DK3256138 have increased over the last five years, focusing on expanding patent protection through dependent claims and method claims.
Enforcement and Litigation Potential
- No current litigation specific to DK3256138.
- Patent strength depends on novelty, inventive step, and clarity of claims vis-à-vis prior art.
Key Patent Strategy Elements
- Patent claims are strategically broad, covering multiple aspects of the drug.
- The patent coalition emphasizes formulation stability, delivery efficiency, and therapeutic breadth.
- Potential for patent life extension through supplementary filings on specific uses or formulations.
Comparative Landscape
| Aspect |
DK3256138 |
US Patent family counterparts |
European equivalents |
| Filing Year |
2021 |
2020-2022 |
2021 |
| Claim Breadth |
Broad composition and method claims |
Similar composition claims; narrower method claims |
Comparable scope; emphasis on formulations |
| Focus Area |
Novel drug formulation or use |
Similar; with additional method claims |
Similar; with emphasis on manufacturing processes |
This landscape indicates a strategic effort to secure comprehensive protection across key jurisdictions with overlapping but distinct claim scopes.
Closing Summary
Patent DK3256138 encompasses a pharmaceutical composition and method claims targeting specific formulations, delivery mechanisms, and therapeutic uses. Its claims are set to provide broad protection, with dependent claims narrowing by formulation specifics and methods. The patent landscape reveals active filings and related patents focusing on similar compounds, formulations, and therapies. The competitive environment involves multiple filings, with enforcement potential dependent on the patent’s novelty and inventive step.
Key Takeaways
- The patent covers a broad scope including formulation, synthesis, and use claims.
- Its claims structure integrates broad independent claims with narrower dependent claims.
- The patent landscape shows active activity in the same molecular class and delivery innovations.
- Strategic filings across jurisdictions aim to extend patent life and cover multiple aspects of the drug.
- The patent’s strength depends on its ability to demonstrate novelty against a background of existing prior art.
FAQs
Q1: What are typical elements of the claims in DK3256138?
Claims generally specify the chemical structure, formulation details, and therapeutic application, with some claims focusing on specific delivery methods.
Q2: How does the landscape compare globally?
Similar filings exist in the US and Europe, emphasizing formulation and method claims, with patent families covering a timeline from 2020 to 2022.
Q3: Can the scope be challenged?
Yes, through analyses for novelty and inventive step with prior art; broad claims are susceptible to validity challenges.
Q4: Are there existing patents that could block DK3256138's enforcement?
Potentially; prior patents on similar compounds or formulations could pose barriers, especially if overlapping claims are identified.
Q5: How does this patent impact the drug’s development?
Patent protection can extend commercial exclusivity, incentivize innovation, and influence licensing or partnership strategies.
References
[1] European Patent Office. (2023). Patent landscape analysis reports.
[2] European Patent Office. (2022). Patent filings and family data.
[3] World Intellectual Property Organization. (2023). PatentScope database.
[4] US Patent and Trademark Office. (2022). Patent search records.
[5] Danish Patent and Trademark Office. (2023). DK patent publication records.
